The London Clinic is proud to announce they are the first private hospital in the UK to offer patients a new non-invasive treatment option for non-melanoma skin cancers: Rhenium-SCT®.
The treatment, developed by German-based company OncoBeta®, uses the chemical element rhenium to deliver a controlled dosage of radiation to the skin surface, treating superficial skin cancers precisely and painlessly. Results are impressive, showing complete tumour regression in 98.5% of lesions treated.
Dr. Gerhard Dahlhoff, Medical Director for OncoBeta® said, “The treatment is designed for non-melanoma skin cancer, which is an abnormal growth of cells that usually (but not always) develops on an area of skin that has been highly exposed to the sun. It grows more slowly than melanoma and is less likely to spread. However, it still requires treatment to stop it growing and possibly spreading.”
Following a Dermatologist referral, patients will be able to come to The London Clinic to be assessed by the radiation specialist, and then booked in for this treatment. Patients without a Dermatologist referral can still access this treatment if suitable by booking an appointment in the Dermatology Clinic at The London Clinic’s Rapid Diagnostics Centre.
The treatment will begin with the dermatologist marking the required area, after which the nuclear medicine specialist can then apply a radioactive paste to the skin surface. The treatment takes approximately 30 to 180 minutes depending on the size and depth of the area needed to treat. Once the paste is removed, the procedure is complete and patients can go home.
The London Clinic’s Consultant Dermatologist Dr Bashir said, “This is a very exciting treatment because it’s non-invasive, completely painless and does not require any anaesthetic or surgery. In most cases only one treatment session is required, and the patient can literally walk in and walk out.”
“Most treatments for skin cancer require a surgical procedure and a degree of aftercare or wound care, such as stitches or dressings. No aftercare is needed for the Rhenium-SCT® treatment.”
Rhenium-SCT® can treat any non-melanoma skin cancer. Its particular advantages lie in the treatment of patients with multiple lesions at one time, since no serious side effects are to be expected due to the low depth of action. It’s also good for elderly patients, those with allergies, comorbidities or a low pain tolerance, and is recommended for those with tumors in high-risk or difficult to treat areas, where surgery has been refused, cases where surgery would result in functional mutilation cases where relapse has occurred, and for patients who have been diagnosed with either basal cell carcinoma or squamous cell carcinoma.
To find out more about this treatment and whether it may be an option for you, visit our new webpage HERE.
For information about the following services and to book, please visit: Our GP services – Dermatology Clinic and Rapid Diagnostics Centre.
About OncoBeta®:
OncoBeta® with its headquarters located in Garching near Munich, Germany, is a privately held medical device company, specialising in the development and commercialisation of state-of-the-art, innovative therapies. Since its foundation, OncoBeta® has concentrated its efforts on the development, regulatory approval(s) and commercialisation of the epidermal radioisotope therapy Rhenium-SCT® (Skin Cancer Therapy), targeting non-melanoma skin cancers. OncoBeta® has perfected the customised application and device management system in conformity with all health, safety, and environmental protection regulatory standards.
About The London Clinic:
The London Clinic is a leading private charitable hospital, situated in Harley Street, the heart of London’s medical district. Opened in February 1932 by the Duke and Duchess of York (later becoming King George VI), The London Clinic has been at the forefront of healthcare for over 90 years.
Her Majesty The Queen (formerly HRH The Duchess of Cornwall) is The London Clinic’s Patron.
It’s services are provided across seven buildings housing eleven theatres, 190 beds, consulting rooms, and a wide range of diagnostic services, including the latest 3T MRI scanner. The Duchess of Devonshire Wing, The London Clinic’s custom-built cancer centre, spans eight floors, offering access to state-of-the-art radiotherapy and chemotherapy suites, along with Europe’s largest private stem cell collection and storage facility. We were the first independent hospital in the UK to gain the Joint Accreditation Committee ISCT Europe and EBMT (JACIE) accreditation in recognition of our quality standards in stem cell work. We also have a Rapid Diagnostics Centre (opened February 2024) which focuses on urology, gynaecology, breast and dermatology, as well as supports a focus on early diagnosis particularly in cancer.
As a full-service hospital, The London Clinic offers the most comprehensive range of services of any UK private hospital, including a 13-bed, Level 3 Intensive Care Unit and in-house pathology laboratory. We employ over 1,300 expert nurses, allied healthcare professionals, doctors, and support roles. Our 900 world-class consultants specialise in cancer care, digestive diseases, orthopaedics (including hips, knees, shoulders, and fingers with on-site physiotherapy rehabilitation), neurology, cosmetic surgery, liver services, gastroenterology, urology, endoscopy, diabetes, haematology, and endocrinology.
As a charity, The London Clinic reinvests all profits to further our mission of advancing healthcare within our hospital and for the benefit of the healthcare community. We were the first private hospital in the UK to introduce robotic surgery for prostate cancer and SpyGlass technology for endoscopy. We continue to invest significantly in the education of our people, supporting nurses to complete their degrees and fellows to become consultants.
